Research strategy 2024-2026

CIRS generated its 2024-2026 research plan with significant input from its Scientific Advisory Council (SAC) and HTA Steering Committee. Priority areas were identified and fleshed out through meetings of Topic Groups in 2022-2023, which focused on:

• Patient engagement
• Expedited pathways in regulation and HTA
• Metrics.

Feedback from these groups, careful review of the landscape as well as conversations with various CIRS member companies, agencies and other stakeholders, were reviewed and organised into the following strategy. This will be achieved through research projects, workshops and other meetings,and is grouped into three themes: